Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

    ... Fludarabine Mycophenolate Mofetil Phase:  Phase 2 ...

    Clinical Trial last updated 05/03/2016 - 10:51am.

  2. Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

    ... Cyclosporine Fludarabine Mycophenolate Mofetil Phase:  Phase 2 ...

    Clinical Trial last updated 05/03/2016 - 9:44am.

  3. Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant

    ... Associated Drug(s):  Mycophenolate Mofetil Phase:  Phase 1 ...

    Clinical Trial last updated 05/23/2016 - 2:06pm.

  4. Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease

    ... the body's normal cells. Giving cyclosporine and mycophenolate mofetil after transplant may stop this from happening. ...

    Clinical Trial last updated 04/29/2016 - 1:56pm.

  5. Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

    ... graft-versus-host disease). Giving cyclosporine and mycophenolate mofetil before and after transplant may stop this from happening. ...

    Clinical Trial last updated 04/28/2016 - 1:52pm.

  6. Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Sy

    ... body's normal cells. Giving cyclophosphamide together with mycophenolate mofetil and tacrolimus after the transplant may stop this from happening. ...

    Clinical Trial last updated 04/28/2016 - 1:01pm.

  7. T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

    ... Cyclophosphamide Mycophenolate Mofetil Phase:  Phase 2 ...

    Clinical Trial last updated 05/03/2016 - 11:43am.

  8. Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

    ... irradiation, donor bone marrow transplant , mycophenolate mofetil, and tacrolimus in treating patients with hematologic cancer. Giving ...

    Clinical Trial last updated 04/29/2016 - 12:48pm.

  9. Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

    ... before the transplant together with cyclosporine and mycophenolate mofetil after the transplant may stop this from happening. ...

    Clinical Trial last updated 04/28/2016 - 1:11pm.

  10. Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia

    ... Fludarabine Mycophenolate Mofetil Phase:  Phase 1 ...

    Clinical Trial last updated 04/29/2016 - 12:58pm.